scholarly journals An integrated magneto-electrochemical device for the rapid profiling of tumour extracellular vesicles from blood plasma

Author(s):  
Jongmin Park ◽  
Jun Seok Park ◽  
Chen-Han Huang ◽  
Ala Jo ◽  
Kaitlyn Cook ◽  
...  
2021 ◽  
Vol 10 (10) ◽  
Author(s):  
Glenn Vergauwen ◽  
Joeri Tulkens ◽  
Cláudio Pinheiro ◽  
Francisco Avila Cobos ◽  
Sándor Dedeyne ◽  
...  

2017 ◽  
Vol 6 (1) ◽  
pp. 1308779 ◽  
Author(s):  
Morten Mørk ◽  
Aase Handberg ◽  
Shona Pedersen ◽  
Malene M. Jørgensen ◽  
Rikke Bæk ◽  
...  

2019 ◽  
Vol 173 ◽  
pp. 141-150 ◽  
Author(s):  
Morten Mørk ◽  
Jan J. Andreasen ◽  
Lars H. Rasmussen ◽  
Gregory Y.H. Lip ◽  
Shona Pedersen ◽  
...  

Open Biology ◽  
2020 ◽  
Vol 10 (6) ◽  
pp. 200116 ◽  
Author(s):  
Sandra Anne Banack ◽  
Rachael Anne Dunlop ◽  
Paul Alan Cox

Biomarkers for amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) are currently not clinically available for disease diagnosis or analysis of disease progression. If identified, biomarkers could improve patient outcomes by enabling early intervention and assist in the determination of treatment efficacy. We hypothesized that neural-enriched extracellular vesicles could provide microRNA (miRNA) fingerprints with unequivocal signatures of neurodegeneration. Using blood plasma from ALS/MND patients and controls, we extracted neural-enriched extracellular vesicle fractions and conducted next-generation sequencing and qPCR of miRNA components of the transcriptome. We here report eight miRNA sequences which significantly distinguish ALS/MND patients from controls in a replicated experiment using a second cohort of patients and controls. miRNA sequences from patient blood samples using neural-enriched extracellular vesicles may yield unique insights into mechanisms of neurodegeneration and assist in early diagnosis of ALS/MND.


Cells ◽  
2019 ◽  
Vol 8 (9) ◽  
pp. 1046 ◽  
Author(s):  
Božič ◽  
Sitar ◽  
Junkar ◽  
Štukelj ◽  
Pajnič ◽  
...  

Extracellular vesicles (EVs) isolated from biological samples are a promising material for use in medicine and technology. However, the assessment methods that would yield repeatable concentrations, sizes and compositions of the harvested material are missing. A plausible model for the description of EV isolates has not been developed. Furthermore, the identity and genesis of EVs are still obscure and the relevant parameters have not yet been identified. The purpose of this work is to better understand the mechanisms taking place during harvesting of EVs, in particular the role of viscosity of EV suspension. The EVs were harvested from blood plasma by repeated centrifugation and washing of samples. Their size and shape were assessed by using a combination of static and dynamic light scattering. The average shape parameter of the assessed particles was found to be ρ ~ 1 (0.94–1.1 in exosome standards and 0.7–1.2 in blood plasma and EV isolates), pertaining to spherical shells (spherical vesicles). This study has estimated the value of the viscosity coefficient of the medium in blood plasma to be 1.2 mPa/s. It can be concluded that light scattering could be a plausible method for the assessment of EVs upon considering that EVs are a dynamic material with a transient identity.


2021 ◽  
Author(s):  
Laura Cantone ◽  
Mirjam Hoxha ◽  
Chiara Favero ◽  
Luca Ferrari ◽  
Valentina Bollati

Abstract Extracellular vesicles (EVs) play a key role in many physiological and pathological processes [1]. EVs are a heterogeneous group of membrane-confined particles including endosome-derived exosomes and plasma membrane-originated microvesicles. The expanding field of extracellular vesicle research needs reproducible and accurate methods to characterize EVs [2]. EV profiling can be challenging due to the small size and heterogeneity. This protocol aims to provide a method to isolate EVs and facilitate high-precision particle quantitation by Nanoparticle Tracking Analysis (NTA)[3, 4]. NTA is commonly used to determine EV concentration and diameter [5, 6]. The protocol here described refers to the isolation of EVs from blood-plasma samples by using ultracentrifugation and then quantification and sizing of EVs with NTA by NanoSight NS300 system (Malvern Panalytical Ltd., Malvern, UK) provided with a syringe pump module enabling analysis in constant flow for improved sample statistics.


Sign in / Sign up

Export Citation Format

Share Document